UT-B

UT-B (SLC14A1) is a facilitative urea transporter that mediates transmembrane urea flux and plays a central role in maintaining urea homeostasis across multiple tissues, particularly erythrocytes and the renal medulla^[1][2]. Mechanistically, UT-B supports rapid urea movement along concentration gradients, enabling efficient urea recycling within the renal medullary microenvironment and contributing to the urinary concentrating mechanism^[1][3]. In erythrocytes, UT-B markedly increases urea permeability and protects cells from osmotic stress during passage through regions of high urea concentration, thereby helping preserve erythrocyte stability and morphology^[2][1]. Experimental studies using UT-B-deficient mice demonstrate that loss of UT-B causes a urea-selective urine-concentrating defect and reveals additional phenotypes in the bladder, brain, heart, and reproductive system, highlighting the broad physiological importance of UT-B-mediated urea transport^[1][2]. In the urinary tract, UT-B deficiency is associated with increased intracellular urea accumulation, altered expression of genes involved in DNA damage and apoptosis, and urothelial abnormalities in experimental models^[2]. Compared with the related UT-A isoforms (SLC14A2), which are predominantly expressed in renal epithelial cells and mediate transepithelial urea transport, UT-B exhibits a broader tissue distribution and contributes to both renal and extrarenal physiological functions^[1][3]. For experimental applications, UT-B activity can be inhibited by compounds such as phloretin and several urea analogues, making UT-B a useful target for mechanistic studies of urea transport and the development of urea transporter-directed pharmacological strategies^[2][4].